Deegtal is a technology company that provides solutions to enhance the efficiency and accuracy of epilepsy diagnosis.
Deegtal has raised $809K in total funding. The most recent round was Grant. The last funding was announced in September 2025.
Deegtal's investors include Venture Kick, Innosuisse, Wyss Center, DayOne accelerator.
Deegtal is headquartered in Geneva, Switzerland.
Deegtal is a technology company that provides solutions to enhance the efficiency and accuracy of epilepsy diagnosis.
Deegtal is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Deegtal — Funding & Investors." VCBacked, September 23, 2025, https://www.vcbacked.co/company/deegtal. Accessed July 19, 2026.
VCBacked. (2025). Deegtal — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/deegtal
{{cite web |title=Deegtal — Funding & Investors |url=https://www.vcbacked.co/company/deegtal |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated